Global Peptide Cancer Vaccine Sales Market Report 2023

Global Peptide Cancer Vaccine Sales Market Report 2023

Table of Contents
1 Peptide Cancer Vaccine Market Overview
1.1 Peptide Cancer Vaccine Product Scope
1.2 Peptide Cancer Vaccine Segment by Pipeline
1.2.1 Global Peptide Cancer Vaccine Sales by Pipeline (2018 & 2022 & 2029)
1.2.2 ITK-1
1.2.3 GRN-1201
1.2.4 TPIV200
1.2.5 TPIV110
1.2.6 UV1
1.2.7 Galinpepimut-S
1.2.8 TARP 27-35
1.2.9 HER-Vaxx
1.2.10 Vx-001
1.2.11 Others
1.3 Peptide Cancer Vaccine Segment by Application
1.3.1 Global Peptide Cancer Vaccine Sales Comparison by Application (2018 & 2022 & 2029)
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Melanoma
1.3.5 Prostate Cancer
1.3.6 Others
1.4 Peptide Cancer Vaccine Market Estimates and Forecasts (2018-2029)
1.4.1 Global Peptide Cancer Vaccine Market Size in Value Growth Rate (2018-2029)
1.4.2 Global Peptide Cancer Vaccine Market Size in Volume Growth Rate (2018-2029)
1.4.3 Global Peptide Cancer Vaccine Price Trends (2018-2029)
2 Peptide Cancer Vaccine Estimates and Forecasts by Region
2.1 Global Peptide Cancer Vaccine Market Size by Region: 2018 VS 2022 VS 2029
2.2 Global Peptide Cancer Vaccine Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Peptide Cancer Vaccine Sales Market Share by Region (2018-2023)
2.2.2 Global Peptide Cancer Vaccine Revenue Market Share by Region (2018-2023)
2.3 Global Peptide Cancer Vaccine Market Estimates and Forecasts by Region (2024-2029)
2.3.1 Global Peptide Cancer Vaccine Sales Estimates and Forecasts by Region (2024-2029)
2.3.2 Global Peptide Cancer Vaccine Revenue Forecast by Region (2024-2029)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Peptide Cancer Vaccine Estimates and Projections (2018-2029)
2.4.2 Europe Peptide Cancer Vaccine Estimates and Projections (2018-2029)
2.4.3 China Peptide Cancer Vaccine Estimates and Projections (2018-2029)
2.4.4 Japan Peptide Cancer Vaccine Estimates and Projections (2018-2029)
2.4.5 Southeast Asia Peptide Cancer Vaccine Estimates and Projections (2018-2029)
2.4.6 India Peptide Cancer Vaccine Estimates and Projections (2018-2029)
3 Global Peptide Cancer Vaccine Competition Landscape by Players
3.1 Global Top Peptide Cancer Vaccine Players by Sales (2018-2023)
3.2 Global Top Peptide Cancer Vaccine Players by Revenue (2018-2023)
3.3 Global Peptide Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptide Cancer Vaccine as of 2022)
3.4 Global Peptide Cancer Vaccine Average Price by Company (2018-2023)
3.5 Manufacturers Peptide Cancer Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Peptide Cancer Vaccine Market Size by Pipeline
4.1 Global Peptide Cancer Vaccine Historic Market Review by Pipeline (2018-2023)
4.1.1 Global Peptide Cancer Vaccine Sales by Pipeline (2018-2023)
4.1.2 Global Peptide Cancer Vaccine Revenue by Pipeline (2018-2023)
4.1.3 Global Peptide Cancer Vaccine Price by Pipeline (2018-2023)
4.2 Global Peptide Cancer Vaccine Market Estimates and Forecasts by Pipeline (2024-2029)
4.2.1 Global Peptide Cancer Vaccine Sales Forecast by Pipeline (2024-2029)
4.2.2 Global Peptide Cancer Vaccine Revenue Forecast by Pipeline (2024-2029)
4.2.3 Global Peptide Cancer Vaccine Price Forecast by Pipeline (2024-2029)
5 Global Peptide Cancer Vaccine Market Size by Application
5.1 Global Peptide Cancer Vaccine Historic Market Review by Application (2018-2023)
5.1.1 Global Peptide Cancer Vaccine Sales by Application (2018-2023)
5.1.2 Global Peptide Cancer Vaccine Revenue by Application (2018-2023)
5.1.3 Global Peptide Cancer Vaccine Price by Application (2018-2023)
5.2 Global Peptide Cancer Vaccine Market Estimates and Forecasts by Application (2024-2029)
5.2.1 Global Peptide Cancer Vaccine Sales Forecast by Application (2024-2029)
5.2.2 Global Peptide Cancer Vaccine Revenue Forecast by Application (2024-2029)
5.2.3 Global Peptide Cancer Vaccine Price Forecast by Application (2024-2029)
6 United States Peptide Cancer Vaccine Market Facts & Figures
6.1 United States Peptide Cancer Vaccine Sales by Company
6.1.1 United States Peptide Cancer Vaccine Sales by Company (2018-2023)
6.1.2 United States Peptide Cancer Vaccine Revenue by Company (2018-2023)
6.2 United States Peptide Cancer Vaccine Sales Breakdown by Pipeline
6.2.1 United States Peptide Cancer Vaccine Sales Breakdown by Pipeline (2018-2023)
6.2.2 United States Peptide Cancer Vaccine Sales Breakdown by Pipeline (2024-2029)
6.3 United States Peptide Cancer Vaccine Sales Breakdown by Application
6.3.1 United States Peptide Cancer Vaccine Sales Breakdown by Application (2018-2023)
6.3.2 United States Peptide Cancer Vaccine Sales Breakdown by Application (2024-2029)
7 Europe Peptide Cancer Vaccine Market Facts & Figures
7.1 Europe Peptide Cancer Vaccine Sales by Company
7.1.1 Europe Peptide Cancer Vaccine Sales by Company (2018-2023)
7.1.2 Europe Peptide Cancer Vaccine Revenue by Company (2018-2023)
7.2 Europe Peptide Cancer Vaccine Sales Breakdown by Pipeline
7.2.1 Europe Peptide Cancer Vaccine Sales Breakdown by Pipeline (2018-2023)
7.2.2 Europe Peptide Cancer Vaccine Sales Breakdown by Pipeline (2024-2029)
7.3 Europe Peptide Cancer Vaccine Sales Breakdown by Application
7.3.1 Europe Peptide Cancer Vaccine Sales Breakdown by Application (2018-2023)
7.3.2 Europe Peptide Cancer Vaccine Sales Breakdown by Application (2024-2029)
8 China Peptide Cancer Vaccine Market Facts & Figures
8.1 China Peptide Cancer Vaccine Sales by Company
8.1.1 China Peptide Cancer Vaccine Sales by Company (2018-2023)
8.1.2 China Peptide Cancer Vaccine Revenue by Company (2018-2023)
8.2 China Peptide Cancer Vaccine Sales Breakdown by Pipeline
8.2.1 China Peptide Cancer Vaccine Sales Breakdown by Pipeline (2018-2023)
8.2.2 China Peptide Cancer Vaccine Sales Breakdown by Pipeline (2024-2029)
8.3 China Peptide Cancer Vaccine Sales Breakdown by Application
8.3.1 China Peptide Cancer Vaccine Sales Breakdown by Application (2018-2023)
8.3.2 China Peptide Cancer Vaccine Sales Breakdown by Application (2024-2029)
9 Japan Peptide Cancer Vaccine Market Facts & Figures
9.1 Japan Peptide Cancer Vaccine Sales by Company
9.1.1 Japan Peptide Cancer Vaccine Sales by Company (2018-2023)
9.1.2 Japan Peptide Cancer Vaccine Revenue by Company (2018-2023)
9.2 Japan Peptide Cancer Vaccine Sales Breakdown by Pipeline
9.2.1 Japan Peptide Cancer Vaccine Sales Breakdown by Pipeline (2018-2023)
9.2.2 Japan Peptide Cancer Vaccine Sales Breakdown by Pipeline (2024-2029)
9.3 Japan Peptide Cancer Vaccine Sales Breakdown by Application
9.3.1 Japan Peptide Cancer Vaccine Sales Breakdown by Application (2018-2023)
9.3.2 Japan Peptide Cancer Vaccine Sales Breakdown by Application (2024-2029)
10 Southeast Asia Peptide Cancer Vaccine Market Facts & Figures
10.1 Southeast Asia Peptide Cancer Vaccine Sales by Company
10.1.1 Southeast Asia Peptide Cancer Vaccine Sales by Company (2018-2023)
10.1.2 Southeast Asia Peptide Cancer Vaccine Revenue by Company (2018-2023)
10.2 Southeast Asia Peptide Cancer Vaccine Sales Breakdown by Pipeline
10.2.1 Southeast Asia Peptide Cancer Vaccine Sales Breakdown by Pipeline (2018-2023)
10.2.2 Southeast Asia Peptide Cancer Vaccine Sales Breakdown by Pipeline (2024-2029)
10.3 Southeast Asia Peptide Cancer Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia Peptide Cancer Vaccine Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Peptide Cancer Vaccine Sales Breakdown by Application (2024-2029)
11 India Peptide Cancer Vaccine Market Facts & Figures
11.1 India Peptide Cancer Vaccine Sales by Company
11.1.1 India Peptide Cancer Vaccine Sales by Company (2018-2023)
11.1.2 India Peptide Cancer Vaccine Revenue by Company (2018-2023)
11.2 India Peptide Cancer Vaccine Sales Breakdown by Pipeline
11.2.1 India Peptide Cancer Vaccine Sales Breakdown by Pipeline (2018-2023)
11.2.2 India Peptide Cancer Vaccine Sales Breakdown by Pipeline (2024-2029)
11.3 India Peptide Cancer Vaccine Sales Breakdown by Application
11.3.1 India Peptide Cancer Vaccine Sales Breakdown by Application (2018-2023)
11.3.2 India Peptide Cancer Vaccine Sales Breakdown by Application (2024-2029)
12 Company Profiles and Key Figures in Peptide Cancer Vaccine Business
12.1 Boston Biomedical
12.1.1 Boston Biomedical Corporation Information
12.1.2 Boston Biomedical Business Overview
12.1.3 Boston Biomedical Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Boston Biomedical Peptide Cancer Vaccine Products Offered
12.1.5 Boston Biomedical Recent Development
12.2 Ultimovacs
12.2.1 Ultimovacs Corporation Information
12.2.2 Ultimovacs Business Overview
12.2.3 Ultimovacs Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Ultimovacs Peptide Cancer Vaccine Products Offered
12.2.5 Ultimovacs Recent Development
12.3 BrightPath Biotherapeutics
12.3.1 BrightPath Biotherapeutics Corporation Information
12.3.2 BrightPath Biotherapeutics Business Overview
12.3.3 BrightPath Biotherapeutics Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
12.3.4 BrightPath Biotherapeutics Peptide Cancer Vaccine Products Offered
12.3.5 BrightPath Biotherapeutics Recent Development
12.4 TapImmune
12.4.1 TapImmune Corporation Information
12.4.2 TapImmune Business Overview
12.4.3 TapImmune Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
12.4.4 TapImmune Peptide Cancer Vaccine Products Offered
12.4.5 TapImmune Recent Development
12.5 Immatics
12.5.1 Immatics Corporation Information
12.5.2 Immatics Business Overview
12.5.3 Immatics Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Immatics Peptide Cancer Vaccine Products Offered
12.5.5 Immatics Recent Development
12.6 Sellas
12.6.1 Sellas Corporation Information
12.6.2 Sellas Business Overview
12.6.3 Sellas Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Sellas Peptide Cancer Vaccine Products Offered
12.6.5 Sellas Recent Development
12.7 Imugene
12.7.1 Imugene Corporation Information
12.7.2 Imugene Business Overview
12.7.3 Imugene Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
12.7.4 Imugene Peptide Cancer Vaccine Products Offered
12.7.5 Imugene Recent Development
12.8 VAXON Biotech
12.8.1 VAXON Biotech Corporation Information
12.8.2 VAXON Biotech Business Overview
12.8.3 VAXON Biotech Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
12.8.4 VAXON Biotech Peptide Cancer Vaccine Products Offered
12.8.5 VAXON Biotech Recent Development
12.9 Generex Biotechnology
12.9.1 Generex Biotechnology Corporation Information
12.9.2 Generex Biotechnology Business Overview
12.9.3 Generex Biotechnology Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
12.9.4 Generex Biotechnology Peptide Cancer Vaccine Products Offered
12.9.5 Generex Biotechnology Recent Development
12.10 ISA Pharmaceuticals
12.10.1 ISA Pharmaceuticals Corporation Information
12.10.2 ISA Pharmaceuticals Business Overview
12.10.3 ISA Pharmaceuticals Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
12.10.4 ISA Pharmaceuticals Peptide Cancer Vaccine Products Offered
12.10.5 ISA Pharmaceuticals Recent Development
12.11 OncoTherapy Science
12.11.1 OncoTherapy Science Corporation Information
12.11.2 OncoTherapy Science Business Overview
12.11.3 OncoTherapy Science Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
12.11.4 OncoTherapy Science Peptide Cancer Vaccine Products Offered
12.11.5 OncoTherapy Science Recent Development
13 Peptide Cancer Vaccine Manufacturing Cost Analysis
13.1 Peptide Cancer Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Peptide Cancer Vaccine
13.4 Peptide Cancer Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Peptide Cancer Vaccine Distributors List
14.3 Peptide Cancer Vaccine Customers
15 Market Dynamics
15.1 Peptide Cancer Vaccine Industry Trends
15.2 Peptide Cancer Vaccine Market Drivers
15.3 Peptide Cancer Vaccine Market Challenges
15.4 Peptide Cancer Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Peptide Cancer Vaccine Sales (US$ Million) Growth Rate by Pipeline (2018 & 2022 & 2029)
Table 2. Global Peptide Cancer Vaccine Sales ((US$ Million)) Comparison by Application (2018 & 2022 & 2029)
Table 3. Global Peptide Cancer Vaccine Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029
Table 4. Global Peptide Cancer Vaccine Sales (K Units) by Region (2018-2023)
Table 5. Global Peptide Cancer Vaccine Sales Market Share by Region (2018-2023)
Table 6. Global Peptide Cancer Vaccine Revenue (US$ Million) Market Share by Region (2018-2023))
Table 7. Global Peptide Cancer Vaccine Revenue Share by Region (2018-2023)
Table 8. Global Peptide Cancer Vaccine Sales (K Units) Forecast by Region (2024-2029)
Table 9. Global Peptide Cancer Vaccine Sales Market Share Forecast by Region (2024-2029)
Table 10. Global Peptide Cancer Vaccine Revenue (US$ Million) Forecast by Region (2024-2029)
Table 11. Global Peptide Cancer Vaccine Revenue Share Forecast by Region (2024-2029)
Table 12. Global Peptide Cancer Vaccine Sales by Company (K Units) & (2018-2023)
Table 13. Global Peptide Cancer Vaccine Sales Share by Company (2018-2023)
Table 14. Global Peptide Cancer Vaccine Revenue by Company (US$ Million) & (2018-2023)
Table 15. Global Peptide Cancer Vaccine Revenue Share by Company (2018-2023)
Table 16. Global Peptide Cancer Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Cancer Vaccine as of 2022)
Table 17. Global Market Peptide Cancer Vaccine Average Price by Company (USD/Unit) & (2018-2023)
Table 18. Manufacturers Peptide Cancer Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Peptide Cancer Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Peptide Cancer Vaccine Sales by Pipeline (2018-2023) & (K Units)
Table 22. Global Peptide Cancer Vaccine Sales Share by Pipeline (2018-2023)
Table 23. Global Peptide Cancer Vaccine Revenue by Pipeline (2018-2023) & (US$ Million)
Table 24. Global Peptide Cancer Vaccine Price by Pipeline (2018-2023) & (USD/Unit)
Table 25. Global Peptide Cancer Vaccine Sales by Pipeline (2024-2029)
Table 26. Global Peptide Cancer Vaccine Revenue by Pipeline (2024-2029) & (US$ Million)
Table 27. Global Peptide Cancer Vaccine Revenue Share by Pipeline (2024-2029)
Table 28. Global Peptide Cancer Vaccine Price by Pipeline (2024-2029) & (USD/Unit)
Table 29. Global Peptide Cancer Vaccine Sales by Application (2018-2023) & (K Units)
Table 30. Global Peptide Cancer Vaccine Sales Share by Application (2018-2023)
Table 31. Global Peptide Cancer Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 32. Global Peptide Cancer Vaccine Price by Application (2018-2023) & (USD/Unit)
Table 33. Global Peptide Cancer Vaccine Sales by Application (2024-2029) & (K Units)
Table 34. Global Peptide Cancer Vaccine Sales Share by Application (2024-2029)
Table 35. Global Peptide Cancer Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Peptide Cancer Vaccine Revenue Share by Application (2024-2029)
Table 37. Global Peptide Cancer Vaccine Price by Application (2024-2029) & (USD/Unit)
Table 38. United States Peptide Cancer Vaccine Sales by Company (2018-2023) & (K Units)
Table 39. United States Peptide Cancer Vaccine Sales Market Share by Company (2018-2023)
Table 40. United States Peptide Cancer Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 41. United States Peptide Cancer Vaccine Revenue Market Share by Company (2018-2023)
Table 42. United States Peptide Cancer Vaccine Sales by Pipeline (2018-2023) & (K Units)
Table 43. United States Peptide Cancer Vaccine Sales Market Share by Pipeline (2018-2023)
Table 44. United States Peptide Cancer Vaccine Sales by Pipeline (2024-2029) & (K Units)
Table 45. United States Peptide Cancer Vaccine Sales Market Share by Pipeline (2024-2029)
Table 46. United States Peptide Cancer Vaccine Sales by Application (2018-2023) & (K Units)
Table 47. United States Peptide Cancer Vaccine Sales Market Share by Application (2018-2023)
Table 48. United States Peptide Cancer Vaccine Sales by Application (2024-2029) & (K Units)
Table 49. United States Peptide Cancer Vaccine Sales Market Share by Application (2024-2029)
Table 50. Europe Peptide Cancer Vaccine Sales by Company (2018-2023) & (K Units)
Table 51. Europe Peptide Cancer Vaccine Sales Market Share by Company (2018-2023)
Table 52. Europe Peptide Cancer Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 53. Europe Peptide Cancer Vaccine Revenue Market Share by Company (2018-2023)
Table 54. Europe Peptide Cancer Vaccine Sales by Pipeline (2018-2023) & (K Units)
Table 55. Europe Peptide Cancer Vaccine Sales Market Share by Pipeline (2018-2023)
Table 56. Europe Peptide Cancer Vaccine Sales by Pipeline (2024-2029) & (K Units)
Table 57. Europe Peptide Cancer Vaccine Sales Market Share by Pipeline (2024-2029)
Table 58. Europe Peptide Cancer Vaccine Sales by Application (2018-2023) & (K Units)
Table 59. Europe Peptide Cancer Vaccine Sales Market Share by Application (2018-2023)
Table 60. Europe Peptide Cancer Vaccine Sales by Application (2024-2029) & (K Units)
Table 61. Europe Peptide Cancer Vaccine Sales Market Share by Application (2024-2029)
Table 62. China Peptide Cancer Vaccine Sales by Company (2018-2023) & (K Units)
Table 63. China Peptide Cancer Vaccine Sales Market Share by Company (2018-2023)
Table 64. China Peptide Cancer Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 65. China Peptide Cancer Vaccine Revenue Market Share by Company (2018-2023)
Table 66. China Peptide Cancer Vaccine Sales by Pipeline (2018-2023) & (K Units)
Table 67. China Peptide Cancer Vaccine Sales Market Share by Pipeline (2018-2023)
Table 68. China Peptide Cancer Vaccine Sales by Pipeline (2024-2029) & (K Units)
Table 69. China Peptide Cancer Vaccine Sales Market Share by Pipeline (2024-2029)
Table 70. China Peptide Cancer Vaccine Sales by Application (2018-2023) & (K Units)
Table 71. China Peptide Cancer Vaccine Sales Market Share by Application (2018-2023)
Table 72. China Peptide Cancer Vaccine Sales by Application (2024-2029) & (K Units)
Table 73. China Peptide Cancer Vaccine Sales Market Share by Application (2024-2029)
Table 74. Japan Peptide Cancer Vaccine Sales by Company (2018-2023) & (K Units)
Table 75. Japan Peptide Cancer Vaccine Sales Market Share by Company (2018-2023)
Table 76. Japan Peptide Cancer Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 77. Japan Peptide Cancer Vaccine Revenue Market Share by Company (2018-2023)
Table 78. Japan Peptide Cancer Vaccine Sales by Pipeline (2018-2023) & (K Units)
Table 79. Japan Peptide Cancer Vaccine Sales Market Share by Pipeline (2018-2023)
Table 80. Japan Peptide Cancer Vaccine Sales by Pipeline (2024-2029) & (K Units)
Table 81. Japan Peptide Cancer Vaccine Sales Market Share by Pipeline (2024-2029)
Table 82. Japan Peptide Cancer Vaccine Sales by Application (2018-2023) & (K Units)
Table 83. Japan Peptide Cancer Vaccine Sales Market Share by Application (2018-2023)
Table 84. Japan Peptide Cancer Vaccine Sales by Application (2024-2029) & (K Units)
Table 85. Japan Peptide Cancer Vaccine Sales Market Share by Application (2024-2029)
Table 86. Southeast Asia Peptide Cancer Vaccine Sales by Company (2018-2023) & (K Units)
Table 87. Southeast Asia Peptide Cancer Vaccine Sales Market Share by Company (2018-2023)
Table 88. Southeast Asia Peptide Cancer Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 89. Southeast Asia Peptide Cancer Vaccine Revenue Market Share by Company (2018-2023)
Table 90. Southeast Asia Peptide Cancer Vaccine Sales by Pipeline (2018-2023) & (K Units)
Table 91. Southeast Asia Peptide Cancer Vaccine Sales Market Share by Pipeline (2018-2023)
Table 92. Southeast Asia Peptide Cancer Vaccine Sales by Pipeline (2024-2029) & (K Units)
Table 93. Southeast Asia Peptide Cancer Vaccine Sales Market Share by Pipeline (2024-2029)
Table 94. Southeast Asia Peptide Cancer Vaccine Sales by Application (2018-2023) & (K Units)
Table 95. Southeast Asia Peptide Cancer Vaccine Sales Market Share by Application (2018-2023)
Table 96. Southeast Asia Peptide Cancer Vaccine Sales by Application (2024-2029) & (K Units)
Table 97. Southeast Asia Peptide Cancer Vaccine Sales Market Share by Application (2024-2029)
Table 98. India Peptide Cancer Vaccine Sales by Company (2018-2023) & (K Units)
Table 99. India Peptide Cancer Vaccine Sales Market Share by Company (2018-2023)
Table 100. India Peptide Cancer Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 101. India Peptide Cancer Vaccine Revenue Market Share by Company (2018-2023)
Table 102. India Peptide Cancer Vaccine Sales by Pipeline (2018-2023) & (K Units)
Table 103. India Peptide Cancer Vaccine Sales Market Share by Pipeline (2018-2023)
Table 104. India Peptide Cancer Vaccine Sales by Pipeline (2024-2029) & (K Units)
Table 105. India Peptide Cancer Vaccine Sales Market Share by Pipeline (2024-2029)
Table 106. India Peptide Cancer Vaccine Sales by Application (2018-2023) & (K Units)
Table 107. India Peptide Cancer Vaccine Sales Market Share by Application (2018-2023)
Table 108. India Peptide Cancer Vaccine Sales by Application (2024-2029) & (K Units)
Table 109. India Peptide Cancer Vaccine Sales Market Share by Application (2024-2029)
Table 110. Boston Biomedical Corporation Information
Table 111. Boston Biomedical Description and Business Overview
Table 112. Boston Biomedical Peptide Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Boston Biomedical Peptide Cancer Vaccine Product
Table 114. Boston Biomedical Recent Development
Table 115. Ultimovacs Corporation Information
Table 116. Ultimovacs Description and Business Overview
Table 117. Ultimovacs Peptide Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Ultimovacs Peptide Cancer Vaccine Product
Table 119. Ultimovacs Recent Development
Table 120. BrightPath Biotherapeutics Corporation Information
Table 121. BrightPath Biotherapeutics Description and Business Overview
Table 122. BrightPath Biotherapeutics Peptide Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. BrightPath Biotherapeutics Peptide Cancer Vaccine Product
Table 124. BrightPath Biotherapeutics Recent Development
Table 125. TapImmune Corporation Information
Table 126. TapImmune Description and Business Overview
Table 127. TapImmune Peptide Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. TapImmune Peptide Cancer Vaccine Product
Table 129. TapImmune Recent Development
Table 130. Immatics Corporation Information
Table 131. Immatics Description and Business Overview
Table 132. Immatics Peptide Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Immatics Peptide Cancer Vaccine Product
Table 134. Immatics Recent Development
Table 135. Sellas Corporation Information
Table 136. Sellas Description and Business Overview
Table 137. Sellas Peptide Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Sellas Peptide Cancer Vaccine Product
Table 139. Sellas Recent Development
Table 140. Imugene Corporation Information
Table 141. Imugene Description and Business Overview
Table 142. Imugene Peptide Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Imugene Peptide Cancer Vaccine Product
Table 144. Imugene Recent Development
Table 145. VAXON Biotech Corporation Information
Table 146. VAXON Biotech Peptide Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 147. VAXON Biotech Description and Business Overview
Table 148. VAXON Biotech Peptide Cancer Vaccine Product
Table 149. VAXON Biotech Recent Development
Table 150. Generex Biotechnology Corporation Information
Table 151. Generex Biotechnology Peptide Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 152. Generex Biotechnology Description and Business Overview
Table 153. Generex Biotechnology Peptide Cancer Vaccine Product
Table 154. Generex Biotechnology Recent Development
Table 155. ISA Pharmaceuticals Corporation Information
Table 156. ISA Pharmaceuticals Description and Business Overview
Table 157. ISA Pharmaceuticals Peptide Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. ISA Pharmaceuticals Peptide Cancer Vaccine Product
Table 159. ISA Pharmaceuticals Recent Development
Table 160. OncoTherapy Science Corporation Information
Table 161. OncoTherapy Science Description and Business Overview
Table 162. OncoTherapy Science Peptide Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 163. OncoTherapy Science Peptide Cancer Vaccine Product
Table 164. OncoTherapy Science Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Peptide Cancer Vaccine Distributors List
Table 168. Peptide Cancer Vaccine Customers List
Table 169. Peptide Cancer Vaccine Market Trends
Table 170. Peptide Cancer Vaccine Market Drivers
Table 171. Peptide Cancer Vaccine Market Challenges
Table 172. Peptide Cancer Vaccine Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Cancer Vaccine Product Picture
Figure 2. Global Peptide Cancer Vaccine Sales (US$ Million) by Pipeline (2018 & 2022 & 2029)
Figure 3. Global Peptide Cancer Vaccine Sales Market Share by Pipeline in 2022 & 2029
Figure 4. ITK-1 Product Picture
Figure 5. GRN-1201 Product Picture
Figure 6. TPIV200 Product Picture
Figure 7. TPIV110 Product Picture
Figure 8. UV1 Product Picture
Figure 9. Galinpepimut-S Product Picture
Figure 10. TARP 27-35 Product Picture
Figure 11. HER-Vaxx Product Picture
Figure 12. Vx-001 Product Picture
Figure 13. Others Product Picture
Figure 14. Global Peptide Cancer Vaccine Sales (US$ Million) by Application (2018 & 2022 & 2029)
Figure 15. Global Peptide Cancer Vaccine Sales Market Share by Application in 2022 & 2029
Figure 16. Breast Cancer Examples
Figure 17. Lung Cancer Examples
Figure 18. Melanoma Examples
Figure 19. Prostate Cancer Examples
Figure 20. Others Examples
Figure 21. Global Peptide Cancer Vaccine Sales, (US$ Million), 2018 VS 2022 VS 2029
Figure 22. Global Peptide Cancer Vaccine Sales Growth Rate (2018-2029) & (US$ Million)
Figure 23. Global Peptide Cancer Vaccine Sales (K Units) Growth Rate (2018-2029)
Figure 24. Global Peptide Cancer Vaccine Price Trends Growth Rate (2018-2029) & (USD/Unit)
Figure 25. Global Market Peptide Cancer Vaccine Market Size (US$ Million) by Region:2018 VS 2022 VS 2029
Figure 26. Global Peptide Cancer Vaccine Revenue Market Share by Region: 2018 VS 2022
Figure 27. United States Peptide Cancer Vaccine Revenue (US$ Million) Growth Rate (2018-2029)
Figure 28. United States Peptide Cancer Vaccine Sales (K Units) Growth Rate (2018-2029)
Figure 29. Europe Peptide Cancer Vaccine Revenue (US$ Million) Growth Rate (2018-2029)
Figure 30. Europe Peptide Cancer Vaccine Sales (US$ Million) Growth Rate (2018-2029)
Figure 31. China Peptide Cancer Vaccine Revenue (US$ Million) Growth Rate (2018-2029)
Figure 32. China Peptide Cancer Vaccine Sales (US$ Million) and Growth Rate (2018-2029)
Figure 33. Japan Peptide Cancer Vaccine Revenue (US$ Million) Growth Rate (2018-2029)
Figure 34. Japan Peptide Cancer Vaccine Sales (US$ Million) Growth Rate (2018-2029)
Figure 35. Southeast Asia Peptide Cancer Vaccine Revenue (US$ Million) Growth Rate (2018-2029)
Figure 36. Southeast Asia Peptide Cancer Vaccine Sales (US$ Million) Growth Rate (2018-2029)
Figure 37. India Peptide Cancer Vaccine Revenue (US$ Million) Growth Rate (2018-2029)
Figure 38. India Peptide Cancer Vaccine Sales (US$ Million) Growth Rate (2018-2029)
Figure 39. Global 5 Largest Peptide Cancer Vaccine Players Market Share by Revenue in Peptide Cancer Vaccine: 2018 & 2022
Figure 40. Peptide Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 41. Global Peptide Cancer Vaccine Revenue Share by Pipeline (2018-2023)
Figure 42. Global Peptide Cancer Vaccine Sales Share by Pipeline (2024-2029)
Figure 43. Global Peptide Cancer Vaccine Revenue Share by Pipeline (2024-2029)
Figure 44. Global Peptide Cancer Vaccine Revenue Share by Application (2018-2023)
Figure 45. Global Peptide Cancer Vaccine Revenue Growth Rate by Application in 2018 & 2022
Figure 46. Global Peptide Cancer Vaccine Sales Share by Application (2024-2029)
Figure 47. Global Peptide Cancer Vaccine Revenue Share by Application (2024-2029)
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Peptide Cancer Vaccine
Figure 50. Manufacturing Process Analysis of Peptide Cancer Vaccine
Figure 51. Peptide Cancer Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global BCG Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global BCG Vaccine market size was valued at US$ 365.6 million in 2023. With growing demand in downstream market, the BCG Vaccine is forecast to a readjusted size of US$ 542.8 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global BCG Vaccine market. BCG Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Peptide Cancer Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Peptide Cancer Vaccine market size was valued at US$ 535 million in 2023. With growing demand in downstream market, the Peptide Cancer Vaccine is forecast to a readjusted size of US$ 1978.2 million by 2030 with a CAGR of 20.5% during review period. The research report highlights the growth potential of the global Peptide Cancer Vaccine market. Peptide Cancer Vaccine are expected to show stable growth in the future market. How......

Global Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Vaccine market: According to our latest research, the global Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Cancer Vaccine market was estimated at USD 7198.2 million, and it's anticipated to reach USD 33936.62 million in 2028, with a CAGR of 29.49% during the forecast years. A cancer vaccine is a type of immunotherapy that boost the body's natural defenses by stimulating the immune system to recognize and cur......

Global Lung Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Lung Cancer Vaccines market: According to our latest research, the global Lung Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Lung Cancer Vaccines market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Lung Cancer Vaccines,A cancer vaccine for lung cance This report covers a research time span from 2018 to 2028, and ......

Global Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 105

Market Overview of Global Cancer Vaccines market: According to our latest research, the global Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Cancer Vaccines market was estimated at USD 5773.14 million, and it's anticipated to reach USD 15406.41 million in 2028, with a CAGR of 17.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Vacci......

Global Dendritic Cell Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 110

Market Overview of Global Dendritic Cell Cancer Vaccine market: According to our latest research, the global Dendritic Cell Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Dendritic Cell Cancer Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Dendritic cells (DC) are one of the major antigen presenting cells found in lymphoid organs. The main fu......

Global BCG Vaccine Market Research Report 2023, Forecast to 2028

Published: 14-Nov-2023        Price: US 2680 Onwards        Pages: 135

BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......

Global BCG Vaccine Professional Survey Report 2023, Forecast to 2028

Published: 14-Nov-2023        Price: US 3280 Onwards        Pages: 105

BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......

Infectious Vaccine Collaboration and Licensing Deals 2016-2023

Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300

Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious vaccine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of infectious vaccine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter infectious vaccine deals. These deals tend to be multicomponent, starting with......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs